Brief: Imaging Biometrics Announces Soft Close To Phase 1 Trial of Oral Gallium Maltolate
21/07/2025 07:37
July 21 (Reuters) - Imaging Biometrics Ltd IBAI.L: IMAGING BIOMETRICS - IB ANNOUNCES SOFT CLOSE TO PHASE 1 TRIAL IMAGING BIOMETRICS LTD - TRIAL REMAINS ACTIVE, NO NEW RECRUITMENT Source text: ID:nRSU8287Ra Further company coverage: IBAI.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Imaging Biometrics
See all newsImaging Biometrics - US Academic Medical Centre Adopts IB Clinic
Imaging Biometrics - Half Yearly Report to 30 June 2026
Imaging Biometrics - Sub-division
Brief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
Brief: Imaging Biometrics Says Expectation Of Progress Towards Profitability In 2026 Is Unchanged